Mometasone Teva (Mometasone Furoate)

Mometasone furoate, the active ingredient in Mometasone Teva, is a corticosteroid presented as a nasal spray for endosinusial use. It is indicated for the treatment of allergic rhinitis and nasal polyps in adults and appropriate pediatric patients.

GNH USA supplies Mometasone Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mometasone Teva is a topical corticosteroid used in the nasal cavity to reduce inflammation associated with allergic and obstructive conditions.

- Allergic rhinitis: alleviates nasal congestion, itching, and sneezing caused by allergic inflammation. - Nasal polyps: reduces polyp size and improves nasal airflow. - Seasonal allergic rhinitis: provides symptom relief during pollen seasons.

Mometasone Teva may cause local and systemic adverse reactions.

Common Side Effects: - Nasal irritation or burning sensation - Headache - Epistaxis (nosebleed) - Throat irritation or dryness - Cough - Altered taste perception

Serious or Rare Side Effects: - Nasal septal perforation - Severe allergic reaction (anaphylaxis) - Vision changes (e.g., cataracts, glaucoma) - Adrenal suppression with prolonged use - Opportunistic fungal infection of the nasal passages - Systemic corticosteroid effects such as hyperglycemia

Before using Mometasone Teva, consider the following safety measures.

- Pregnancy: consult a healthcare professional before use. - Breastfeeding: discuss potential risks with a physician. - Children: follow prescriber guidance regarding age‑appropriate dosing. - Prolonged use: avoid extended therapy to reduce risk of systemic effects. - Nasal infection: do not use if active infection is present without medical advice. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Mometasone Teva can interact with other medications; monitor accordingly.

Major Interactions (Avoid): - Systemic corticosteroids: may increase overall corticosteroid exposure. - Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): can raise local drug levels.

Moderate Interactions (Monitor Closely): - Antifungal agents (e.g., fluconazole) - Antiretroviral drugs (e.g., ritonavir) - Diuretics (may affect electrolyte balance) - Non‑steroidal anti‑inflammatory drugs (risk of nasal bleeding) - Live vaccines (potentially reduced immune response)